---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000862920.md"
description: "$Pfizer(PFE.US)Pfizer has been showing signs of a strong recovery, climbing toward US$28 as markets rotate into defensive healthcare names. Its improving earnings outlook, recurring cash flow, attractive dividend and pipeline developments continue to support the stock.As expected preferred to secure the some gain and moving on to the next opportunity during reboundWatching Pfizer can hold above the support level and break through  resistance. Keeping an eye on earnings recovery, oncology and vaccine pipeline developments, dividend strength and broader defensive sector rotationDrug pricing pressure, pipeline execution and slower than expected revenue growth could weigh on the stock"
datetime: "2026-08-20T15:45:40.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000862920.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000862920.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000862920.md)
author: "[Victor y](https://longbridge.com/en/profiles/22453176.md)"
generator: "portal-rs"
---

# $Pfizer(PFE.US)Pfizer has been showing signs of a …


### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Comments (1)

- **Fattycat · 2026-08-20T23:40:52.000Z**: 👍


---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**